Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655
@article{Szabados2001ComparisonOA, title={Comparison of anticonvulsive and acute neuroprotective activity of three 2,3-benzodiazepine compounds, GYKI 52466, GYKI 53405, and GYKI 53655}, author={Tam{\'a}s Szabados and G{\'a}bor Gigler and Istv{\'a}n Gacs{\'a}lyi and Istv{\'a}n Gyerty{\'a}n and Gy{\"o}rgy L{\'e}vay}, journal={Brain Research Bulletin}, year={2001}, volume={55}, pages={387-391} }
45 Citations
Protective effect of the antiepileptic drug candidate talampanel against AMPA-induced striatal neurotoxicity in neonatal rats
- BiologyBrain Research Bulletin
- 2002
Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent.
- BiologyBioorganic & medicinal chemistry
- 2008
Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives.
- ChemistryJournal of medicinal chemistry
- 2003
New cyclofunctionalized 2,3-benzodiazepines characterized by a triazolone or triazindione ring fused on the "c" edge of the heptatomic nucleus have been prepared and some of them proved to be more potent noncompetitive 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propionate (AMPA) receptor antagonists.
Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike–wave discharges in a genetic rat model of absence epilepsy
- BiologyBrain Research
- 2004
Fused Diazepines. Synthesis of 2-Methyl-8-aryl-4,6-dihydro-5H-thieno[3',2':4,5]thieno[2,3-d][1,2]diazepin-5-ones
- ChemistryRussian Journal of Organic Chemistry
- 2021
Heterocyclization of ethyl 2-acetyl(aroyl)-5-methylthieno[2,3-b]thiophene-3-acetates with hydrazine hydrate has been studied. A dependence of the reaction direaction on the nature of the substituent…
Blockade of AMPA-receptors attenuates 4-aminopyridine seizures, decreases the activation of inhibitory neurons but is ineffective against seizure-related astrocytic swelling
- Biology, MedicineEpilepsy Research
- 2008
Comparison of the AMPA Antagonist Action of New 2,3-Benzodiazepines in Vitro and Their Neuroprotective Effects in Vivo
- BiologyPharmaceutical Research
- 2004
In vitro efficacy and in vivo neuroprotective action of new 2,3-benzodiazepine (2,3BDZ) AMPA antagonists have been compared for testing the hypothesis that blockade of AMPA receptors might result in significant protection of neurons against cellular damage.
SYNTHESE DE NOUVELLES 1,5-BENZODIAZEPINES ASSOCIANT DIFFERENTS HETEROCYCLES A CINQ CHAINONS
- Chemistry
- 2004
Nous décrivons la synthèse de nouvelles isoxazolinyl, pyrazolinyl, pyrazolyl et 1,2,3-triazolylméthylsulfanyl-1,5-benzodiazépines, ainsi que l'allylsulfanyl-1,2,4-triazolo-1,5-benzodiazépine par…
AMPA receptor antagonists as potential anticonvulsant drugs.
- Biology, ChemistryCurrent topics in medicinal chemistry
- 2005
Over the last years alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors (AMPARs) have been intensively studied owing to their crucial role in physiological and pathological…
Repeated 4-aminopyridine induced seizures diminish the efficacy of glutamatergic transmission in the neocortex
- BiologyExperimental Neurology
- 2009
References
SHOWING 1-10 OF 23 REFERENCES
GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice.
- Chemistry, BiologyEuropean journal of pharmacology
- 1995
Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.
- Chemistry, BiologyThe Journal of pharmacology and experimental therapeutics
- 1994
The increased affinity of the 3-N-substituted analogs relates to their increased binding and decreased unbinding rates, which are inversely correlated with increasing blocking potency.
The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice
- Biology, ChemistryEpilepsy Research
- 1991
GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses
- BiologyNeuron
- 1993
Anticonvulsant actions of DS 103–282 Pharmacological studies in rodents and the baboon, Papio papio
- Medicine, BiologyNeuropharmacology
- 1984
Cerebroprotective Effect of a Non–N‐Methyl‐D‐Aspartate Antagonist, GYKI 52466, After Focal Ischemia in the Rat
- Medicine, BiologyStroke
- 1992
The cerebroprotective effect of GYKI 52466 in the rat suggests a possible therapeutic role for non-N-methyl-D-aspartate antagonists given shortly after the onset of stroke.
Investigations of non-NMDA receptor-induced toxicity in serum-free antioxidant-rich primary cultures of murine cerebellar granule cellsfn2
fn2
Abbreviations: AMPA, α amino-3-hydroxy-5-methyl-4-isoxazole propionate; CNQX, 6-Cyano-7-nitroquinoxaline-2,3-dione; div, days in vitro; GABA, γ-aminobu
- Biology, ChemistryNeurochemistry International
- 1998
Effects of the non‐NMDA antagonists NBQX and the 2,3‐benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil
- BiologyBritish journal of pharmacology
- 1994
The data indicate that the GABAA receptor‐associated benzodiazepine site is not critically involved in anticonvulsant or adverse effects of GYKI 52466, and demonstrates that non‐NMDA antagonists lack a selective anticonVulsant action in standard models of generalized seizures.
Activity of 2,3-benzodiazepines at Native Rat and Recombinant Human Glutamate Receptors In Vitro: Stereospecificity and Selectivity Profiles
- Biology, ChemistryNeuropharmacology
- 1996
Effect of glutamate receptor antagonists on excitatory postsynaptic potentials in striatum
- BiologyBrain Research Bulletin
- 1998